Name | (5Z)-5-[[5-(4-fluorophenyl)-1H-pyrazol-4-yl]methylidene]-2-imino-3-(1,3-thiazol-2-yl)-1,3-thiazolidin-4-one |
---|---|
Synonyms |
(5Z)-5-{[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]methylene}-2-imino-3-(1,3-thiazol-2-yl)-1,3-thiazolidin-4-one
HMS621M06 necrotatin-7 Necrostatin-7 Nec-7 5-[[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]methylene]-2-imino-3-(2-thiazolyl)-4-thiazolidinone Nec-7 4-Thiazolidinone, 5-[[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methylene]-2-imino-3-(2-thiazolyl)-, (5Z)- |
Description | Necrotatin-7 (Nec-7) is a potent necroptosis inhibitor with an EC50 of 10.6 μM. Necrotatin-7 does not inhibit recombinant RIP1 kinase[1]. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 613.4±65.0 °C at 760 mmHg |
Molecular Formula | C16H10FN5OS2 |
Molecular Weight | 371.412 |
Flash Point | 324.8±34.3 °C |
Exact Mass | 371.031067 |
PSA | 139.27000 |
LogP | 2.73 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.805 |
~90% 351062-08-3 |
Literature: PRESIDENT AND FELLOWS OF HARVARD COLLEGE; SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES; YUAN, Junying; YUAN, Chengye; DEGTEREV, Alexei Patent: WO2010/75290 A1, 2010 ; Location in patent: Page/Page column 45 ; |
Precursor 1 | |
---|---|
DownStream 0 |